Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) COO Sells $278,884.56 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of the stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now directly owns 122,676 shares in the company, valued at $1,461,071.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Cardlytics Trading Up 6.3 %

CDLX stock opened at $12.31 on Friday. Cardlytics, Inc. has a 52 week low of $4.94 and a 52 week high of $20.52. The company has a market capitalization of $592.97 million, a PE ratio of -3.56 and a beta of 1.44. The company’s 50-day simple moving average is $11.29 and its 200 day simple moving average is $9.66. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.31 and a current ratio of 1.31.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%. The business had revenue of $89.17 million during the quarter.

Analysts Set New Price Targets

A number of research analysts recently commented on CDLX shares. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and upped their price target for the company from $10.00 to $18.00 in a research note on Friday, March 15th. Lake Street Capital upped their target price on Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Finally, Needham & Company LLC increased their target price on Cardlytics from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Tuesday, April 9th.

Institutional Investors Weigh In On Cardlytics

Several institutional investors have recently made changes to their positions in the stock. Tower Research Capital LLC TRC increased its stake in Cardlytics by 349.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock worth $88,000 after acquiring an additional 7,465 shares during the period. D L Carlson Investment Group Inc. acquired a new stake in shares of Cardlytics during the 3rd quarter worth $173,000. SG Americas Securities LLC increased its position in shares of Cardlytics by 34.3% in the fourth quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock worth $198,000 after purchasing an additional 5,484 shares during the period. Clear Street Markets LLC acquired a new position in Cardlytics in the fourth quarter valued at about $199,000. Finally, Check Capital Management Inc. CA lifted its position in Cardlytics by 14.0% during the fourth quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock worth $214,000 after purchasing an additional 2,850 shares during the period. 68.10% of the stock is currently owned by institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.